STTK
ShattuckยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
STTK Profile
Shattuck Labs, Inc.
A clinical-stage biotech company pioneering bi-functional fusion proteins as a new class of biologic medicine for cancer and autoimmune disease
Biological Technology
05/09/2016
10/09/2020
NASDAQ Stock Exchange
44
12-31
Common stock
500 W. 5th Street, Suite 1200, Austin, TX 78701
--
Shattuck Labs, Inc., was incorporated in Delaware on May 9, 2016. The company is an innovative clinical-stage biotechnology company dedicated to the development of double-sided fusion proteins as an entirely new biomedical product.
